DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

Novartis (NYSE: NVS)

103.85 -0.94 (-0.90%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NVS $103.85 -0.90%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $103.95
Previous Close $104.79
Daily Range $103.81 - $104.56
52-Week Range $84.17 - $105.82
Market Cap $249.1B
P/E Ratio 28.32
Dividend (Yield) $2.67 (2.2%)
Ex-Dividend Date
Dividend Pay Date
03/02/15
04/20/15
Volume 617,104
Average Daily Volume 1,234,674
Current FY EPS $5.24

Sector

Healthcare

Industry

Drug Makers

Novartis (NVS) Description

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products. Website: http://www.novartis.com/

News & Commentary

Could This Be Healthcare's $158 Billion Black Swan Event?

This unlikely event is becoming increasingly more likely -- and the impact would be enormous.

Novartis Announces Positive Data on Oncology Drug Afinitor - Analyst Blog

Novartis Announces Positive Data on Oncology Drug Afinitor - Analyst Blog

Novartis Reports Two Positive US Phase III Programs in COPD for QVA149, NVA237

Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for May 21, 2015

Biosimilars Vs Generics: History Does Not Repeat, It Rhymes

2 Stocks With Jaw-Dropping Growth Potential

These 2 companies are high-risk investments, but they nonetheless have the potential to become pivotal players in the rapidly expanding field of immuno-oncology. Here's why.

Baxter Takes The Acquisition Route To Grow In The Oncology Segment

Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for May 15, 2015

8 Top Healthcare Stocks to Watch

Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for May 14, 2015

See More NVS News...

NVS's Top Competitors

NVS $103.85 (-0.90%)
Current stock: NVS
JNJ $101.35 (-1.04%)
Current stock: JNJ
MRK $59.38 (-1.20%)
Current stock: MRK
GSK $45.26 (-0.66%)
Current stock: GSK